TVP as prerequisite for Push-Dose Pressors (?)

CWATT

Forum Lieutenant
166
41
28
Not to derail my own thread but my original question has largely been answered and I feel like jumping on the band-wagon...

I think there’s a lot for EMS to take from the EmCrit podcasts. In addition to the examples already listed, my personal favourite is his position people should always use generic drug names not trade names; I’ve been waving this flag for a while. It’s a simple practice that can reduce drug errors and patient harm.
 

E tank

Caution: Paralyzing Agent
728
558
93
Not to derail my own thread but my original question has largely been answered and I feel like jumping on the band-wagon...

I think there’s a lot for EMS to take from the EmCrit podcasts. In addition to the examples already listed, my personal favourite is his position people should always use generic drug names not trade names; I’ve been waving this flag for a while. It’s a simple practice that can reduce drug errors and patient harm.
It's only the generation of providers that use drugs after they come off of patent and marketed under generic names that utilize generic nomenclature. New drugs are marketed and prescribed under trade names because of the conditioning by sales reps, trade journals etc. When I trained in anesthesia, the folks that held the position I now hold would use terms like Sublimaze and Norcuron. I and my generation don't. I still say Versed and Diprivan and Zemuron. The younger set coming after me don't. I don't know anyone at all that says apixaban. Just the way the industry is. Old habits die hard.
 
Top